Camp4 Therapeutics (CAMP) Asset Writedowns and Impairment (2025)
Camp4 Therapeutics' (CAMP) quarterly Asset Writedowns and Impairment came in at -$6000.0 in Q4 2025, down 101.21% quarter-over-quarter from $494000.0 in Q3 2025.
Camp4 Therapeutics (CAMP) Asset Writedowns and Impairment (2025) Analysis & Trends
Camp4 Therapeutics has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting -$6000.0 for Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at -$6000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $488000.0 (changed N/A YoY), and the FY2025 annual result was $494000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at -$6000.0 for Q4 2025 at Camp4 Therapeutics, down from $494000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $494000.0 in Q3 2025 to a low of -$6000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | 494,000.00 |
| Sep 30, 2025 | 494,000.00 |